Vancomycin Hydrochloride Price Trend and Forecast
North America
The prices of Vancomycin
Hydrochloride fluctuated in the North American market throughout the third
quarter of 2022, backed by wavering downstream demand from the pharmaceutical
sector. The market value of Vancomycin Hydrochloride decreased in August due to
reduced demand from the downstream pharmaceutical industry. Also, with enough
existing inventories among domestic merchants and traders, the Vancomycin
Hydrochloride API market was feeble. Overall, throughout Q3 2022, the prices
increased with rising inflation in the US market, keeping the market sentiments
robust. The input cost and firm operational rates propelled the market to
witness decreasing trajectory. High input costs and increased freight charges
positively supported the Vancomycin
Hydrochloride prices in the domestic region. With the termination of
Q3, the prices settled at USD 705530/MT CFR Los Angeles with an average
quarterly inclination of 1.20%.
APAC
The third quarter of 2022 saw
conflicting emotions in the Vancomycin Hydrochloride market. Production in
Chinese provinces ceased at the start of Q3 2022 due to adverse weather
conditions and the ramifications of the strict zero-covid rule. Due to sluggish
pharmaceutical industry demand, prices abruptly dropped. Due to consistent
demand and supply market sentiments through the conclusion of the second month
of Q3, the price trend remained downward. The destocking of the current supply
also impacted the Pricing
of Sulfamethoxazole. Price increases in Asia-Pacific started in the
third month of Q3 2022 due to supply chain disruption and unbalanced shipments.
In addition, many changes in supply and demand throughout the quarter impacted
domestic market prices for vancomycin hydrochloride. The value reached USD
630460 /MT at the end of Q3, with an average quarterly declination of 0.99%
Europe
Due to irregular downstream
demand, Vancomycin Hydrochloride market prices fluctuated in the European
countries during the third quarter. The market value of Vancomycin
Hydrochloride first increased in July, then decreased in August, and then
expanded once more in September. Altogether the market trend declined in the
third quarter of 2022. The significant fall in the prices of Vancomycin
Hydrochloride API was backed by decreasing demand from the pharmaceutical
industry. Also, enough inventories among the domestic merchants and suppliers
forced them to lower their quotations to maintain the margin. Also, rising
inflation propelled decreasing demand from the consumer’s end. With the termination
of Q3, the prices settled at USD 720115/MT CFR Hamburg with an average
quarterly declination of 0.67%.
Comments
Post a Comment